Markers of endothelial dysfunction in patients with iodine induced hyperthyroidism;Ocena wybranych parametrów funkcji śródbłonka u osób z nadczynnościa̧ tarczycy indukowana̧ jodem

Endokrynologia Polska

Volumn 57, Issue 3, 2006, Pages 210-217

  Zonenberg, Anna ^a   Telejko, Beata ^a   Szelachowska, Małgorzata ^a   Modzelewska, Anna ^a   Nikołajuk, Agnieszka ^a   Górska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

CRP; Endothelium; Hyperthyroidism; ICAM 1; IL 6; PAI 1; VCAM 1

Indexed keywords

AMIODARONE; BIOLOGICAL MARKER; INTERLEUKIN 6; IODINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERTHYROIDISM; MALE; METABOLISM; MIDDLE AGED; REFERENCE VALUE; SECRETION; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM;

ADULT; AGED; AMIODARONE; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTHYROIDISM; INTERLEUKIN-6; IODINE; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34249933946     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Franklyn JA. Thyroid disease and its treatment: short-and long-term consequences. J R Coll Physicians Lond 1999;33:564-567.
2. Presti CF, Hart RG. Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J 1989;117:976-977. (Pubitemid 19097310)
3. Rogers JS 2nd, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982;97:713-716. (Pubitemid 13251644)
4. Li Y, Chen H, Tan J i wsp. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease-indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest 1998;28:1050-1054. (Pubitemid 29050141)
5. Liu L, Wang X, Lin Z i wsp. Elevated plasma levels of VWF: Ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocr Res 1993;19:123-133. (Pubitemid 23262251)
6. Bossowski A, Urban M, Citko A i wsp. Ocena stȩŻenia wybranych cza̧steczek adhezyjnych (sICAM-1, sVCAM-1 and sP-selectin) u dzieci i młodzieży w chorobach gruczołu tarczowego. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2000;6:79-92. (Pubitemid 34087233)
7. Modelska-Ziółkiewicz A, Gembicki M, Sowiński J i wsp. Rozpuszczalne formy cza̧steczek adhezyjnych sELAM-1 i sICAM-1 w chorobie Gravesa i Basedowa i wolu guzowatym nadczynnym. Pol Arch Med Wewn 2002;109:463-468.
8. Myśliwiec J, Krȩtowski A, Szelachowska M i wsp. Serum L-selectin and ICAM-1 in patients with Graves' ophthalmopathy during treatment with corticosteroids. Immunol Lett 2001;78:123-126. (Pubitemid 32905383)
9. De Bellis A, Di Martino S, Fiordelisi F i wsp. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy. J Clin Endocrinol Metab 1998;83:1222-1225. (Pubitemid 28496397)
10. Wenisch C, Myskiw D, Parschalk B i wsp. Soluble endothelium-associated adhesion molecules in patients with Graves' disease. Clin Exp Immunol 1994;98:240-244. (Pubitemid 24336820)
11. Wenisch C, Myskiw D, Gessl A i wsp. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism. J Clin Endocrinol Metab 1995;80:2122-2126.
12. Bartalena L, Grasso L, Brogioni S i wsp. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-427. (Pubitemid 24061764)
13. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990;127:357-361. (Pubitemid 20370584)
14. Bartalena L, Brogioni S, Grasso L i wsp. Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration. J Endocrinol Invest 1993;16:213-218. (Pubitemid 23137961)
15. Myśliwiec J, Krȩtowski A, Szelachowska M i wsp. Serum proand antiinflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids. Rocz Akad Med Bialymst 1999;44:160-169.
16. Wahrenberg H, Wennlund A, Hoffstedt J. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumor necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 2002;146:607-611. (Pubitemid 34552492)
17. Salvi M, Girasole G, Pedrazzoni M i wsp. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996;81:2976-2979. (Pubitemid 26323895)
18. Salvi M, Pedrazzoni M, Girasole G i wsp. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000;143:197-202. (Pubitemid 30622353)
19. Siddiqi A, Monson JP, Wood DF i wsp. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 1999;84:435-439. (Pubitemid 29075665)
20. Celik I, Akalin S, Erbas T. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 1995;132:668-672.
21. Bartalena L, Brogioni S, Grasso L i wsp. Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab 1994;79:1424-1427. (Pubitemid 24369860)
22. Martino E, Bartalena L, Bogazzi F i wsp. The effects of amiodarone on the thyroid. Endocrine Reviews 2001;22:240-254. (Pubitemid 32458161)
23. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid 2001;11:493-500. (Pubitemid 32494598)
24. Stanbury JB, Ermans AE, Bourdoux P i wsp. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83-100. (Pubitemid 28082626)
25. Kinalska I, Zarzycki W, Zonenberg A i wsp. Wyniki badania wpływu skażenia radiologicznego po katastrofie w Czarnobylu i profilaktyki jodowej na morfologiȩ i czynność tarczycy na terenie północno-wschodniego regionu Polski. Endokrynol Pol 1991;42:215-234.
26. Krȩtowski A, Brzozowska M, Zonenberg A i wsp. Ocena wielkości tarczycy w populacji dzieci szkolnych w wieku 6-13 lat z prawidłowym wydalaniem jodu z moczem a przydatność stosowanych dotychczas wartości referencyjnych. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2005;11:229-36. (Pubitemid 41499376)
27. Sandell EB, Kolthoff IM. Microdetermination of iodine by a catalytic method. Microchim Acta 1937;1:9-25.
28. Makgoba MW, Bernard A, Sanders ME. Cell adhesion/signalling: biology and clinical applications. Eur J Clin Invest 1992;22:443-453.
29. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999;10:27-39. (Pubitemid 29230850)
30. Shong M, Ro HK, Kim YK i wsp. The cytokines, interleukin-1 beta, interleukin-6 and interferon-gamma upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyroid cell line, FRTL-5. Korean J Intern Med 1994;9:88-92.
31. Marazuela M, Postigo AA, Acevedo A i wsp. Adhesion molecules from the LFA-1/ICAM-1, 3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur J Immunol 1994;24:2483-2490. (Pubitemid 24303097)
32. Gearing AJ, Hemingway I, Pigott R i wsp. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667:324-331. (Pubitemid 23061599)
33. De Bellis A, Bizzarro A, Gattoni A i wsp. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma. J Clin Endocrinol Metab 1995;80:2118-2121.
34. Dietrich JB, Kuchler-Bopp S, Boutillier S i wsp. Expression of thyroid hormone receptors alpha and beta-1 messenger RNAs in human endothelial cells. The T3 hormone stimulates the synthesis of the messenger RNA of the intercellular adhesion molecule-1. Cell Mol Biol (Noisy-le-grand) 1997;43:1205-12.
35. Niessen RW, Pfaffendorf BA, Sturk A i wsp. The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells. Thromb Haemost 1995;74:686-92.
36. Burggraaf J, Lalezari S, Emeis JJ i wsp. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001;11:153-160. (Pubitemid 32221038)
37. Senturk T, Kozaci LD, Kok F i wsp. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 2003;26:58-63. (Pubitemid 36741248)
38. Komorowski J, Jankiewicz J, Robak T i wsp. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 1998;60:143-148. (Pubitemid 28157258)
39. Lakatos P, Foldes J, Horvath C i wsp. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 1997;82:78-81. (Pubitemid 27021274)
40. Nakajima K, Yamazaki K, Yamada E i wsp. Amiodarone stimulates interleukin-6 production in cultured human thyrocytes, exerting cytotoxic effects on thyroid follicles in suspension culture. Thyroid 2001;11:101-109. (Pubitemid 32221032)
41. Rość D, Drewniak W, Zastawna E i wsp. Wskaźniki pobudzenia śródbłonka naczyniowego w nadczynności tarczycy. Pol Merkuriusz Lek 1999;6:79-81.
42. Erem C, Ersoz HO, Karti SS i wsp. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002;25:345-350. (Pubitemid 34436130)
43. Lee WY, Suh JY, Rhee EJ i wsp. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med Res 2004;35:540-545.
44. Pearce EN, Bogazzi F, Martino E i wsp. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 2003;13:643-648. (Pubitemid 36993559)